前列腺增生并发膀胱大出血治疗研究

Study of treatment of prostatic hyperplasia concurrent with massive bladder bleeding

目的探究与分析前列腺增生并发大出血的临床诊治对策。方法回顾性分析我院自2010年12月~2012年12月收治的40例前列腺增生并发膀胱大出血患者的临床诊治资料。按照前列腺摘除与未摘除的治疗方法分成两组,每组各20例,观察两组患者抢救成功率以及复发情况。结果前列腺摘除组中有18例抢救成功,抢救成功率为90.00%,前列腺未摘除组中有11例抢救成功,抢救成功率为55.00%,两者相比差异较为显著(P<0.05)。前列腺未摘除组中5例复发,复发率为45.45%,前列腺摘除组中2例复发,复发率为11.11%,两者比较差异显著(P<0.05)。结论对于出现前列腺增生并发膀胱大出血的患者给以积极有效的止血、补液及抗休克治疗能够得到一定的临床效果,但若想极大程度的增加抢救成功率,应及时将患者的前列腺进行摘除,从而提升其存活率。

Objective To explore and analyze the clinical diagnosis and treatment countermeasures for prostatic hyperplasia concurrent with massive bladder bleeding. Methods Clinical diagnosis and treatment data of 40 patients with prostatic hyperplasia concurrent with massive bladder bleeding that were treated in our hospital from December 2010 to December 2012 were analyzed retrospectively. The patients were divided into two groups according to the prostate removal and non-removal treatment, with 20 patients in each group. The rescue success rates and relapse situation of the two groups of patients were observed. Results In the prostate removal group, 18 patients were successfully rescued, with the rescue success rate of 90.00%, and in the prostate non-removal group, 11 patients were successfully rescued, with the rescue success rate of 55.00%, with significant difference between the two groups(P < 0.05). In the prostate non-removal group, 5 patients relapsed, with the relapse rate of 45.45%, and in the prostate removal group, 2 patients relapsed, with the relapse rate of 11.11%, with significant difference between the two groups(P < 0.05). Conclusion For the patients with prostatic hyperplasia concurrent with massive bladder bleeding, active and effective hemostasis, fluid infusion and anti-shock treatment can obtain certain clinical effects, but in order to maximize the rescue success rate and improve the survival rate, timely prostate removal should be implemented.